Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 4
2013 7
2014 5
2015 3
2016 2
2017 3
2018 5
2019 9
2020 5
2021 3
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Paraneoplastic syndromes in ophthalmology.
Parrado-Carrillo A, Alcubierre R, Camós-Carreras A, Sanchez-Dalmau BF. Parrado-Carrillo A, et al. Arch Soc Esp Oftalmol (Engl Ed). 2022 Jun;97(6):350-357. doi: 10.1016/j.oftale.2022.03.006. Epub 2022 Mar 12. Arch Soc Esp Oftalmol (Engl Ed). 2022. PMID: 35292226 Review.
The presence of autoantibodies is helpful in clinical practice but negativity does not exclude this diagnosis. Although evolution and prognosis is linked to primary disease, in some cases specific treatment, usually immunosuppressive therapy, can help improving patients qu …
The presence of autoantibodies is helpful in clinical practice but negativity does not exclude this diagnosis. Although evolution and pro …
Melanoma-associated retinopathy.
Elsheikh S, Gurney SP, Burdon MA. Elsheikh S, et al. Clin Exp Dermatol. 2020 Mar;45(2):147-152. doi: 10.1111/ced.14095. Epub 2019 Nov 19. Clin Exp Dermatol. 2020. PMID: 31742740 Review.
Patients classically present with acute onset night blindness, positive visual phenomena and visual field defects, and typically have significantly reduced quality of life as a result. Early recognition of MAR is of prognostic significance as it can precede the diagnosis o …
Patients classically present with acute onset night blindness, positive visual phenomena and visual field defects, and typically have signif …
Autoimmune retinopathy.
Grange L, Dalal M, Nussenblatt RB, Sen HN. Grange L, et al. Am J Ophthalmol. 2014 Feb;157(2):266-272.e1. doi: 10.1016/j.ajo.2013.09.019. Epub 2013 Sep 29. Am J Ophthalmol. 2014. PMID: 24315290 Free PMC article. Review.
Early treatment attempts are limited by lack of sensitive and specific assays and definitive clinical criteria. CONCLUSIONS: Little is known about the clinical course, prognosis and treatment of autoimmune retinopathy. Additional studies should examine the specifici …
Early treatment attempts are limited by lack of sensitive and specific assays and definitive clinical criteria. CONCLUSIONS: Little is known …
Autoimmune retinopathy.
Braithwaite T, Vugler A, Tufail A. Braithwaite T, et al. Ophthalmologica. 2012;228(3):131-42. doi: 10.1159/000338240. Epub 2012 Jul 28. Ophthalmologica. 2012. PMID: 22846442 Free article. Review.
Delayed diagnosis, and treatment initiation relatively late in the disease course, may contribute to the poor visual prognosis. Various treatments have been attempted, including systemic immunosuppression with steroid and steroid-sparing agents, intravenous immunogl …
Delayed diagnosis, and treatment initiation relatively late in the disease course, may contribute to the poor visual prognosis …
Neuro-ophthalmic manifestations of cancer: a narrative review.
Janetos TM, Volpe NJ, Simon SS. Janetos TM, et al. Chin Clin Oncol. 2022 Jun;11(3):25. doi: 10.21037/cco-21-137. Chin Clin Oncol. 2022. PMID: 35818857 Free article. Review.
BACKGROUND AND OBJECTIVE: Neuro-ophthalmic manifestations of cancer are vast and early recognition of a serious ocular condition due to either cancer or its therapy is important for both vision preservation as well as providing valuable treatment and prognostic information …
BACKGROUND AND OBJECTIVE: Neuro-ophthalmic manifestations of cancer are vast and early recognition of a serious ocular condition due to eith …
Modern neuro-ophthalmological evaluation of patients with pituitary disorders.
Vié AL, Raverot G. Vié AL, et al. Best Pract Res Clin Endocrinol Metab. 2019 Apr;33(2):101279. doi: 10.1016/j.beem.2019.05.003. Epub 2019 May 30. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31178379 Review.
It is important to recognize these neuro-ophthalmological syndromes to achieve early diagnosis and treatment and to improve prognosis. Currently, ophthalmological examination includes precise measuring instruments, such as optical coherence tomography (OCT), which allows t …
It is important to recognize these neuro-ophthalmological syndromes to achieve early diagnosis and treatment and to improve prognosis …
The Enigma of CRB1 and CRB1 Retinopathies.
Ray TA, Cochran KJ, Kay JN. Ray TA, et al. Adv Exp Med Biol. 2019;1185:251-255. doi: 10.1007/978-3-030-27378-1_41. Adv Exp Med Biol. 2019. PMID: 31884620 Review.
Progress on this front will aid in developing molecular diagnostics that can predict disease severity with the ultimate goal of developing therapies for CRB1 retinopathies via gene replacement. ...
Progress on this front will aid in developing molecular diagnostics that can predict disease severity with the ultimate goal of devel …
Distinct clinical characteristics of paraneoplastic optic neuropathy.
Xu Q, Du W, Zhou H, Zhang X, Liu H, Song H, Wang X, Wei S. Xu Q, et al. Br J Ophthalmol. 2019 Jun;103(6):797-801. doi: 10.1136/bjophthalmol-2018-312046. Epub 2018 Jul 18. Br J Ophthalmol. 2019. PMID: 30021813
OBJECTIVE: Paraneoplastic optic neuropathy (PON) is relatively uncommon, and the visual outcomes and prognosis of this disease have not been well documented. The aim of this study was to investigate the clinical features and prognosis of antibody-mediated PON. ...CO …
OBJECTIVE: Paraneoplastic optic neuropathy (PON) is relatively uncommon, and the visual outcomes and prognosis of this disease have n …
Treatment of Cancer-Associated Retinopathy: A Systematic Literature Review.
Brossard-Barbosa N, Dezard V, Margolin E. Brossard-Barbosa N, et al. Ophthalmol Retina. 2023 Sep;7(9):819-828. doi: 10.1016/j.oret.2023.05.002. Epub 2023 May 7. Ophthalmol Retina. 2023. PMID: 37160190 Review.
CLINICAL RELEVANCE: There is no universally accepted treatment algorithm for CAR and visual prognosis is very poor. We describe a patient with CAR with dramatic improvement in vision after treatment with high doses of corticosteroids followed by plasma exchange (PLEX) and …
CLINICAL RELEVANCE: There is no universally accepted treatment algorithm for CAR and visual prognosis is very poor. We describe a pat …
Cancer-associated retinopathy: update on pathogenesis and therapy.
Shildkrot Y, Sobrin L, Gragoudas ES. Shildkrot Y, et al. Semin Ophthalmol. 2011 Jul-Sep;26(4-5):321-8. doi: 10.3109/08820538.2011.588657. Semin Ophthalmol. 2011. PMID: 21958182 Review.
Recent developments have correlated the disease presentation, course, and therapeutic response to the underlying immune mediators and the inciting antigens. ...
Recent developments have correlated the disease presentation, course, and therapeutic response to the underlying immune mediators and …
47 results